Nian‐Yong Chen

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen et al. · Cancer Communications · 2021 · 374 citations · Full text

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

Wen‐Fei Li, Nian‐Yong Chen, Ning Zhang et al. · International Journal of Cancer · 2019 · 240 citations

Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study

Changjuan Tao, Junlin Yi, Nian‐Yong Chen et al. · Radiotherapy and Oncology · 2015 · 104 citations

Radiation Oncology, Multi-institution Clinical Study, Engineering +12

Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage <scp>IE</scp> to <scp>IIE</scp>, nasal type, extranodal natural killer/T‐cell lymphoma

Li Zhang, Ming Jiang, Li Xie et al. · Cancer Medicine · 2015 · 46 citations · Full text

PD-1 blockade with sintilimab plus induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) versus IC-CCRT in locoregionally-advanced nasopharyngeal carcinoma (LANPC): A multicenter, phase 3, randomized controlled trial (CONTINUUM).

Jun Ma, Ying Sun, Xu Liu et al. · Journal of Clinical Oncology · 2023 · 18 citations

Oncology, Pd-1 Blockade, Clinical Trials +12